MCL1 and diffuse large B-cell lymphoma: Lastly, CDK2/Cyclin E-mediated MCL-1 phosphorylation inhibition by low dinaciclib concentrations sensitized ABT-737-resistant DLBCL cells to apoptosis by encouraging the release of sequestered BIM from MCL-1.